Immediate Impact

2 from Science/Nature 85 standout
Sub-graph 1 of 19

Citing Papers

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
2020 Standout
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020 Standout
40 intermediate papers

Works of A. van Lingen being referenced

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
1989
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.
1987

Author Peers

Author Last Decade Papers Cites
A. van Lingen 269 69 84 334 115 16 693
V. Schiano Lomoriello 323 15 49 564 128 8 719
GL Wismer 392 99 45 217 149 13 704
John C. Powers 79 26 31 431 86 10 576
Pasquale Innelli 234 7 28 515 94 34 676
Stephen Devries 499 16 171 364 204 8 750
Michael Tee 364 30 43 619 102 8 762
Kenji Shiino 317 7 38 602 158 25 696
Lidia Capotosto 154 26 20 599 85 31 781
Ståle Barvik 103 29 53 525 192 21 661
THOMAS W. MOIR 237 11 101 421 176 25 689

All Works

Loading papers...

Rankless by CCL
2026